News + Filings Holdings
|
VHCP Management III, LLC
|
|
Changes: All | New | Increased | Decreased | Sold Out |
Portfolio as of: |
Name | Ticker | Class | Shares | Change | Value | Change | % Port | % OS | Hist | Date |
RELMADA THERAPEUTICS, INC.
| RLMD | Common | 767,938 | 767,938 | 29,950,000 | 29,950,000 | 5.95 | 7.47 |
Hist
| 12/31/2019 |
89bio, Inc.
| ETNB | Common | 958,765 | 958,765 | 25,206,000 | 25,206,000 | 5.00 | 6.95 |
Hist
| 12/31/2019 |
Forty Seven, Inc.
| FTSV | Common | 516,381 | 516,381 | 20,330,000 | 20,330,000 | 4.04 | 1.22 |
Hist
| 12/31/2019 |
Intra-Cellular Therapies, Inc.
| ITCI | Common | 575,000 | 575,000 | 19,728,000 | 19,728,000 | 3.92 | 1.04 |
Hist
| 12/31/2019 |
IVERIC bio, Inc.
| ISEE | COM | 1,699,797 | 1,699,797 | 14,584,000 | 14,584,000 | 2.90 | 4.09 |
Hist
| 12/31/2019 |
Adverum Biotechnologies, Inc.
| ADVM | COM | 946,234 | 946,234 | 10,901,000 | 10,901,000 | 2.16 | 1.47 |
Hist
| 12/31/2019 |
Mersana Therapeutics, Inc.
| MRSN | Common | 1,561,389 | 1,561,389 | 8,947,000 | 8,947,000 | 1.78 | 3.26 |
Hist
| 12/31/2019 |
Myovant Sciences Ltd.
| MYOV | COM | 455,255 | 455,255 | 7,066,000 | 7,066,000 | 1.40 | 0.51 |
Hist
| 12/31/2019 |
NextCure, Inc.
| NXTC | Common | 119,693 | 119,693 | 6,742,000 | 6,742,000 | 1.34 | 0.53 |
Hist
| 12/31/2019 |
|
|
|
|